Facial aging
Conditions
Interventions
Treatment:RF combined with HIFES
Sponsors
Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
Eligibility
Sex/Gender
All
Age
30 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) The patient is aged 30-70 years old, regardless of gender; (2) Bilateral facial symmetry; (3) Moderate to severe facial aging patients with FWS score = 4; (4) No contraindications for RF and electrical stimulation treatment; (5) Not outdoor professional workers; (6) Assess the patient's good compliance and be able to cooperate in completing follow-up; (7) Voluntarily participate in this study and sign an informed consent form.
Exclusion criteria
Exclusion criteria: (1) Muscle or nervous system diseases that have been diagnosed clearly in the past (such as facial atrophy, facial paralysis, etc.); (2) Metal implants in the body (such as dentures, pacemakers, artificial joints, etc.); (3) Pregnant women, lactating women, or women with a pregnancy preparation plan within six months after the end of the study; (4) The combination of facial treatment areas with other skin diseases that may interfere with the treatment or evaluation of facial rejuvenation (such as eczema, allergic dermatitis, severe melasma, psoriasis, rosacea, etc.), or scars, excessive hair, etc. that significantly affect the effectiveness of observation; (5) Participate in other clinical studies on facial rejuvenation during the study period; (6) Those who are unwilling to discontinue the stimulation of other non medical energy devices during the research period and do well in sun protection; (7) Those who have received any facial rejuvenation treatment (such as medication, laser, intense pulsed light, RF, ultrasound, photodynamic therapy, etc.) within the past 4 weeks before enrollment; (8) Complicated systemic diseases: including but not limited to cardiovascular disease history, endocrine diseases (such as diabetes, dyslipidemia, thyroid dysfunction, etc.), blood system diseases (such as anemia, abnormal coagulation mechanism, etc.) or infectious diseases (such as herpes, etc.).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Response rate based on FWS decline index; | — |
Secondary
| Measure | Time frame |
|---|---|
| Response rate based on FWS decline index;Response rate based on GAIS index;Patient satisfaction evaluation; | — |
Countries
China
Contacts
Public ContactMin Yao
Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
Outcome results
None listed